NCT03137576 (PABATS) is a NA clinical trial of Paravertebral Block (PVB) in Lung Neoplasms, sponsored by IRCCS Sacro Cuore Don Calabria di Negrar.

Who is sponsoring NCT03137576?

NCT03137576 is sponsored by IRCCS Sacro Cuore Don Calabria di Negrar.

What drugs are being tested in NCT03137576?

Interventions in NCT03137576: Paravertebral Block (PVB), Erector Spinae Plane Block (ESPB).

What condition does NCT03137576 study?

NCT03137576 studies Lung Neoplasms.

Is NCT03137576 still recruiting?

NCT03137576 is currently terminated. Last updated 11 May 2022.

Last reviewed 2022-05-11 · How we verify

NCT03137576: PABATS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Erector Spinae Plane Block Versus Paravertebral Block During Non-intubated Thoracoscopic Lung Resections.

Terminated NA Last updated 11 May 2022

What this trial tests

NA trial testing Paravertebral Block (PVB) in Lung Neoplasms in 7 participants. Terminated before completion.

Timeline

22 February 2019

Primary endpoint
22 November 2021

22 November 2021

Quick facts

Lead sponsor	IRCCS Sacro Cuore Don Calabria di Negrar
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	7
Start date	22 February 2019
Primary completion	22 November 2021
Estimated completion	22 November 2021
Sites	1 location across Italy

Drugs / interventions tested

Paravertebral Block (PVB)
Erector Spinae Plane Block (ESPB) — full drug profile →

Conditions studied

Lung Neoplasms — all drugs for Lung Neoplasms →

Sponsor

IRCCS Sacro Cuore Don Calabria di Negrar — full company profile →

Who can join

18 and older, any sex, with Lung Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized prospective trial to test the non-inferiority of Erector Spinae Plane Block (ESPB) in comparison with paravertebral block during non-intubated thoracoscopic lung resection

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Randomized controlled trials in lung cancer surgery: How are we doing?
Wong LY, Li Y, Elliott IA, Backhus LM, et al · · 2024 · cited 1× · PMID 38690441 · DOI 10.1016/j.xjon.2024.01.008
Contralateral spontaneous rupture of the esophagus following severe emesis after non-intubated pulmonary wedge resection.
Liu L, Wu W, Gong L, Zhang M. · · 2020 · cited 1× · PMID 33004053 · DOI 10.1186/s13019-020-01321-w

Verify or expand the search:

Other trials of Paravertebral Block (PVB)

Trials testing the same drug.

NCT07241949 — Regional Analgesia Techniques for Laparoscopic Cholecystectomy · NA · not yet recruiting
NCT07211529 — Intraoperative Paravertebral Block and Postoperative Complications · NA · recruiting
NCT06779656 — Regional Anesthesia Techniques in Breast Surgery · NA · not yet recruiting
NCT06584201 — Effects of Erector Spina Plane Block and Paravertebral Block on Early Postoperative Pulmonary Function Test Parameters · recruiting

Other recruiting trials for Lung Neoplasms

Currently open trials in the same condition.

NCT07476287 — Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult · Phase 2 · recruiting
NCT07509333 — MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients · NA · recruiting
NCT07109154 — DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First- · recruiting
NCT06974604 — Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM · Phase 2 · recruiting
NCT07165691 — TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics · NA · recruiting

Other IRCCS Sacro Cuore Don Calabria di Negrar trials

Trials by the same sponsor.

NCT07487506 — Evaluation and Assessment for Communicable Diseases in Migrants Hosted in Reception Centers · NA · recruiting
NCT07009613 — Strongyloides Stercoralis Public Health Control in Rwanda · completed
NCT06308705 — The SsRI/NIE Recombinant Antigen ELISA for the Follow up of Patients Infected by Strongyloides Stercoralis · NA · completed
NCT05884632 — Daily Adaptive RadioTherapy in Postoperative HypofrActionated Salvage radiothERapy for Prostate Cancer Patients · NA · recruiting
NCT05682690 — Laparoscopic Eradication of Deep Endometriosis With Nerve-sparing Rectosigmoid Segmental Resection (RSRES_NERVSP) · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03137576 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by IRCCS Sacro Cuore Don Calabria di Negrar
Last refreshed: 11 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03137576.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing